Document:

<PAGE>

                                                                Exhibit 10.1

                                  AGREEMENT

         THIS AGREEMENT made and entered into as of this 5th day of June,
2002 by and among Forever Network, Inc., a Missouri corporation ("Forever")
and Brent D. Cassity ("Cassity").

         WHEREAS, Cassity entered into a certain Agreement Not to Compete (a
"Non-Compete") with SCI dated February 23, 1996 whereby SCI made certain
monthly payments to Cassity,

         WHEREAS, Forever purchased the assets of the Pfitzinger Funeral
Home, Kirkwood, Missouri from SCI Missouri Funeral Services, Inc. ("SCI")
pursuant to an Asset Purchase Agreement of even date herewith ("Asset
Purchase Agreement"); and

         WHEREAS, a material part of the consideration paid to SCI under the
Asset Purchase Agreement, was the release by Cassity of SCI's continuing
financial obligations under the Non-Compete.

         NOW, THEREFORE, the parties hereto have agreed as follows:

         1.   In consideration of Cassity's release of SCI under the
Non-Compete Agreement, Forever agrees to pay to Cassity the remaining
monthly payments as and when such payments would have been due to Cassity
under the terms of the Non-Compete Agreement, commencing with the June 23,
2002 monthly payment of $4,944.44 and equal payments on the 23rd day of each
month thereafter until the last monthly payment is made on February 23,
2006.

         2.   This Agreement may be executed in two or more counterparts
each of which shall be deemed to be an original, but which together shall
constitute the same instrument.

         3.   This Agreement is governed by the laws of the State of
Missouri.

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement
on the day and year first above written.

                                            FOREVER NETWORK, INC.

                                      By:   /s/ Nekol Province
                                            --------------------------------
                                      Its:  Vice President
                                            --------------------------------

                                                           "Forever"

                                            /s/ Brent D. Cassity
                                            --------------------------------
                                            Brent D. Cassity

                                                           "Cassity"<PAGE>

                                                                Exhibit 10.2

                                  AGREEMENT

         THIS AGREEMENT made and entered into as of this 5th day of June,
2002 by and among Forever Network, Inc., a Missouri corporation ("Forever")
and J. Tyler Cassity ("Cassity").

         WHEREAS, Cassity entered into a certain Agreement Not to Compete (a
"Non-Compete") with SCI dated February 23, 1996 whereby SCI made certain
monthly payments to Cassity,

         WHEREAS, Forever purchased the assets of the Pfitzinger Funeral
Home, Kirkwood, Missouri from SCI Missouri Funeral Services, Inc. ("SCI")
pursuant to an Asset Purchase Agreement of even date herewith ("Asset
Purchase Agreement"); and

         WHEREAS, a material part of the consideration paid to SCI under the
Asset Purchase Agreement, was the release by Cassity of SCI's continuing
financial obligations under the Non-Compete.

         NOW, THEREFORE, the parties hereto have agreed as follows:

         1.   In consideration of Cassity's release of SCI under the
Non-Compete Agreement, Forever agrees to pay to Cassity the remaining
monthly payments as and when such payments would have been due to Cassity
under the terms of the Non-Compete Agreement, commencing with the June 23,
2002 monthly payment of $4,944.44 and equal payments on the 23rd day of each
month thereafter until the last monthly payment is made on February 23,
2006.

         2.   This Agreement may be executed in two or more counterparts
each of which shall be deemed to be an original, but which together shall
constitute the same instrument.

         3.   This Agreement is governed by the laws of the State of
Missouri.

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement
on the day and year first above written.

                                             FOREVER NETWORK, INC.

                                       By:   /s/ Nekol Province
                                             --------------------------------
                                       Its:  Vice President
                                             --------------------------------

                                                            "Forever"

                                             /s/ J. Tyler Cassity
                                             --------------------------------
                                             J. Tyler Cassity

                                                            "Cassity"<PAGE>

                                                                Exhibit 10.2
IBM Letterhead

August 13, 2002

Jerome C. Artigliere
Chief Operating Officer
Applied Digital Solutions, Inc.
218 Royal Palm Way, Suite 201
Palm Beach, Florida 33480

     Re:      Waiver
Dear Mr. Artigliere:

     This letter confirms the agreement between Applied Digital Solutions,
Inc. ("ADS") and IBM Credit Corporation ("IBM" together with ADS, the
"Parties"), with respect to the matters referenced herein.

     On or about July 31, 2002, ADS requested a waiver from IBM of
certain existing defaults under the Third Amended and Restated Term Credit
Agreement entered into by the Parties on March 1, 2002. On August 13, 2002,
IBM agreed to such waiver (the "Waiver") pursuant to the terms and
conditions set forth in the attached e-mail communication between Jerome C.
Artigliere and Bruce Gordon dated August 13, 2002 (the "E-mail").

     Due to the unavailability of IBM's attorneys, the Parties agree that
they will document the Waiver in a formal writing between the Parties by no
later than Wednesday, August 21, 2002, incorporating substantially the same
terms and conditions as are set forth in the E-mail.

     The signature below signifies IBM's agreement to the above. Please sign
in the space provided below to indicate ADS's acceptance.

                                              Very Truly Yours,

                                              /s/[B. Flanagan]

The above letter agreement is accepted and agreed to by ADS this 13 day of
August, 2002.
Applied Digital Solutions, Inc.

By: /s/Jerome C. Artigliere
   ------------------------
Name: Jerome C. Artigliere
Title: Senior Vice President, Chief Operating Officer

<PAGE>
<PAGE>

-Original Message-----
From:     Bruce B Gordon [mailto:gordonbr@us.ibm.com]
Sent:     Tuesday, August 13, 2002 10:36 AM
To:       jartigliere@adsx.com
Cc:       Steven Flanagan; Samuel M Koda; jkkane@JonesDay.com;
tjordak@JonesDay.com; jjsalerno@JonesDay.com; gracesinn@JonesDay.com
Subject:  Waiver conditions

Jerry,

As we discussed earlier this morning, IBM Credit Corporation (ICC) is
agreeable to waiving the existing defaults under your Term Loan & Revolving
Credit Agreement and permitting you to retain $3,383.8K of the proceeds of
the reformed C&H Pier note and the loan due from SysComm with ICC receiving
$1,383.8K. In return we will expect another warrant for 2,894,714 Applied
Digital Solution, Inc. (ADS) shares at $0.15/share and a new warrant for
Verichip Corp. shares equal to 5% of the fully diluted shares of Verichip
Corp. at $0.05/share both in the same form as the present ADS warrant.
Given the vacations of Jim Salerno and Grace Sinn at Jones, Day and of Sam
Koda from ICC, we will put this in formal, signed form next week.

                                   Regards,

                                   Bruce B. Gordon
                                   Program Manager, Special Handling
                                   IBM Credit Corporation
                                   North Castle Drive, Armonk NY 10504
                                   Mail Stop NC317, Office 3D-62C
                                   914-765-6232, T/L 251, fax 928-832-2018
                                   gordonbr@us.ibm.com
                                   Illegitimi non carborundum
                                   Carpe diem, Quam minimum credula postero.

                                    xxishriverconsultingagreement

                    DNAPRINT/MARK SHRIVER CONSULTING CONTRACT

This Consulting Contract Agreement (this "Agreement") is made and entered into
as of June 12, 2002 (the "Effective Date") by and between DNAprint genomics, a
Utah corporation, (hereinafter "DNAPRINT") and Mark Shriver (hereinafter
"CONSULTANT").

Recitals

DNAPRINT is the patent owner of certain SNP markers and methods, and desires to
collaborate with CONSULTANT to develop a kit product that could be used to infer
Ancestry Admixture Ratios in individual human beings.

CONSULTANT is the inventor of certain compositions and methods useful for
determining Ancestry Admixture Ratios in individual human beings. CONSULTANT is
also the owner of certain DNA samples collected from individuals of various
ancestries, and of certain rights therein. CONSULTANT wishes to commercialize
his compositions and methods.

NOW, THEREFORE, in consideration of these premises, as well as the obligations
herein made and undertaken, the parties hereto do hereby agree to develop a
diagnostic kit for the inference of Ancestry Admixture Ratios in individual
human beings. The goals of the PROJECT will be

1) To create a panel of Ancestry Informative Markers (AIMs) that can be
   accurately, specifically and sensitively used to infer the relative
   ancestral admixture ratios in individuals, with respect to a list of target
   ancestral groups. Definitions of adequate accuracy, specifically,
   sensitivity, and target groups will be determined jointly by DNAPRINT and
   CONSULTANT.

2) To evaluate the panel for fitness as a commercial product for immediate
   development.

3) To obtain a license from a third party manufacturer that will allow
   DNAPRINT to efficiently commercialize the product.

                                        1

4) To commercialize the product.

5) To provide customer support for the product.

1. SERVICES

        1.1 Provision. CONSULTANT will provide DNAPRINT with DNA samples. DNAPRINT
            will score genotypes for a panel of Ancestry Informative Markers
            (AIMs) agreed to by both parties. DNAPRINT will transfer this data to
            CONSULTANT. DNAPRINT will provide all necessary consumables, labor and
            equipment for determining and transferring these genotypes. CONSULTANT
            will provide all necessary labor and expertise necessary for
            evaluating these genotype scores. Both parties will contribute towards
            effecting the following plan:

                1.1.1   DNAPrint will genotype all AIMs, in groups of 12, in
                        multiplex. Analyzing the AIMs using DNAPRINT's UHT machine,
                        a single UHT plate of 12 AIMs for 384 individuals at a time.
                        Data will be made for all DNAPRINT and CONSULTANT AIMs
                        together on a single panel of individuals from several
                        target populations, for example African, African-American,
                        European, European-American, Native American, Hispanic, East
                        Asian and South Asian heritage.

                1.1.2   CONSULTANT will evaluate the Admixture proportions and the
                        ability to classify individuals of each ancestral group.

                1.1.3   DNAPRINT and CONSULTANT will define a minimum and optimum
                        set of AIMs necessary for achieving product goals.

                1.1.4   DNAPRINT will modify CONSULTANTS existing computer software
                        programs with the intent of commercializing them to achieve
                        the goals of the project.

                1.1.5   DNAPRINT and CONSULTANT will test the "product" with blind
                        classifications for a selection of individuals representing

                                       2

                        the target groups used to generate allele frequencies in
                        1.1.1 above.

                1.1.6   DNAPRINT will commercialize the product that results (if
                        any). DNAPrint will arrange for mass-production of the
                        plastics and chemicals necessary for use of the kit.

                1.1.7   CONSULTANT will assist DNAPRINT in providing customer
                        support for the product produced by writing documentation
                        for the method and software and outlining procedures for
                        troubleshooting.

2. TERMS

        2.1. Exclusivity. CONSULTANT agrees that DNAPRINT is the exclusive
             beneficiary of his expertise, services, compositions and methods
             related to the goals of the project during the term of this agreement.
             DNAPRINT agrees that CONSULTANT is the company's exclusive CONSULTANT
             for the PROJECT, and that it will not enter into similar relationships
             with others during the term of this agreement.

        2.2. Payment.

                2.2.1.  DNAPRINT will provide CONSULTANT with quarterly payments
                        of $4,000 and 50,000 shares of restricted stock for the term
                        of this contract.

                2.2.2.  DNAPRINT will provide CONSULTANT with 5,000 shares of
                        restricted stock for each $10,000 in net sales that are
                        realized over the life of the products that are generated as
                        a result of this collaboration. In the event of sale of
                        DNAPRINT during the term of this agreement to a party that
                        elects to continue the project/product, CONSULTANT will be
                        paid with shares of the purchasing party using the same
                        stock conversion ratio as used for the purchase. In the
                        event of sale of DNAPRINT during the term of this agreement
                        to a party that does not continue the project under the
                        terms herein, or within one year after the termination date
                        of this agreement, CONSULTANT will be provided with 50% of
                        the proportional that proportion of company value of the
                        company based on attributed by the net present value of the
                        product(s) created though the efforts of this PROJECT, as of
                        the day of the payment.

        2.3. Transfer. DNAPRINT will physically or electronically transfer data to
             CONSULTANT and CONSULTANT will physically or electronically transfer
             samples, software and data in a manner agreed upon by both parties.

        2.4. Expenses. All travel expenses incurred by the CONSUTANT required to
             support this collaboration will be paid by DNAPRINT. All planned
             travel expenses will be pre-approved by the management of DNAPRINT

3. CONTINUATION, TERM and TERMINATION.

        3.1. Services. The term of the agreement is 2 years. After this term, the
             Agreement shall renew for consecutive two year terms unless terminated
             by either party prior to the expiration of a term. If DNAPRINT
             terminates the agreement independently, CONSULTANT continues to
             receive payment as specified in 2.2.2. If CONSULTANT terminates the
             agreement independently after the first 2 year term, CONSULTANT
             continues to receive payments as specified in paragraph 2.2.2.
             However, if the CONSULTANT terminates the agreement independently
             prior to the first two years, paragraph 2.2.2., will not apply. In
             either the case of independent termination by DNAPRINT or CONSULTANT,
             or mutual termination, payments as specified in paragraph 2.2.1. will
             cease after termination. Upon termination, payments as specified in
             paragraph 2.2.1 will be prorated given the date of termination.

        3.2. Termination. In the event that one party wishes to terminate this
             agreement a letter of intent will be sent to the other party as
             stipulated in Section 8.1. After receipt the other party has two weeks
             to respond in writing. One option is to request Mediation and
             Arbitration as defined in Section 7. Alternatively, the other party

                                       4

             could agree to the termination as mutual. Upon discontinuation of the
             agreement, CONSULTANT will return all data directly or indirectly
             enabled by DNAPRINT's contribution to the project to DNAPRINT.

5. RESTRICTIONS ON USE

        5.1 CONSULTANT agrees and understands that any and all data, software
            improvements, methods, compositions and commercial rights are the
            property of DNAPRINT, and that CONSULTANT acquires no rights therein
            and that it can use DNAPRINT data, including any Documentation, only
            for legitimate scientific research as previously approved by DNAPRINT,
            and for no other purpose whatsoever.

        5.2 Privacy. Genotyping data is the property of DNAPRINT, and CONSULTANT
            may not sell, loan, disclose or present DNAPRINT data in any manner
            whatsoever, unless requested by or agreed to by DNAPRINT.

6. Limited Warranty; Limitation of Liability

        6.1 Limited Warranty. DNAPRINT represents and warrants to CONSULTANT that
            DNAPRINT has the authority and licenses necessary to use its
            equipment, compositions and methods for the goals of this project.
            CONSULTANT warrants to DNAPRINT that he is the inventor of record for
            the compositions and methods contributed by CONSULTANT to the project.
            DNAPRINT and CONSULTANT disclaim all other warranties, express or
            implied, with regard to the data, including all implied warranties of
            merchantability, fitness for a particular purpose, title, and
            non-infringement.

        6.2 Limitation on Liability. Neither party shall be liable to the other
            for any indirect, consequential, special or incidental damages
            (including damages for loss of business profits, business
            interruption, loss of business information, and the like) arising out
            of this Agreement even if such party has been advised of the
            possibility of such damages.

7. Mediation and Arbitration

        7.1 Mediation and arbitration approach. The parties agree to select a
            mutually agreeable, neutral third party to help them mediate any
            dispute that arises under the terms of this Agreement. Costs and fees

                                       5

            associated with the mediation will be shared equally by the parties.

        7.2 Arbitration. If the mediation is unsuccessful, the parties agree that
            the dispute will be decided by binding arbitration under the rules of
            the American Arbitration Association. The decision of the arbitrators
            will be final and binding on the parties and may be entered and
            enforced in any court of competent jurisdiction by either party. The
            prevailing party in the arbitration proceedings will be awarded
            reasonable attorney fees, expert witness costs and expenses, and all
            other reasonable costs and expenses incurred in connection with the
            proceedings, unless the arbitrators for good cause determine
            otherwise.

8. General

        8.1 Notices. Any notice required or permitted hereunder must be in
            writing, and will be effective on the date of delivery when delivered
            personally, the next business day after dispatch when sent by Federal
            Express or other recognized overnight courier service, or the fifth
            business day after dispatch when sent by certified mail, postage
            prepaid, return receipt requested. Notices should be addressed to the
            other party at the address shown below or at such other address as a
            party may designate by ten days' advance written notice to the other
            party:

         DNAPRINT GENOMICS, INC.                     MARK SHRIVER.
         900 Cocoanut, Ave.                          720 Hemlock St.
         Sarasota, FL 34236                          Boalsburg, PA 16827

        8.2 Entire Agreement; Modifications. This Agreement constitutes the entire
            agreement of the parties with respect to the subject matter hereof and
            supersedes all prior representations, proposals, discussions, and
            communications, whether oral or in writing. This Agreement may be
            modified or amended only by a writing executed by a duly authorized
            representative of each party.

                                       6

        8.3 Force Majeure. Neither party will be liable to the other for any
            failure or delay caused by events beyond such party's control,
            including, without limitation, sabotage, terrorism, riots,
            insurrections, fires, flood, storm, explosions, war or earthquakes.
            However, if such events have a material impact on the satisfaction of
            this Agreement, and shall continue for thirty (30) days or more, the
            other party shall have the option of terminating this Agreement by
            giving written notice of termination.

        8.4 Change in Law; Change in Circumstances. No party shall make or receive
            any payment or take any action under this Agreement if any judicial
            decision, legislative action, or regulatory or other administrative
            interpretation, whether federal or state, would render illegal the
            conduct of either party under this Agreement. If performance by either
            party of any term of this Agreement should be deemed illegal by any
            party or third party who is essential to performance of this Agreement
            for any such reason, either party shall have the right to require that
            the other party renegotiate the terms of this Agreement.

        8.5 Assignment. This Agreement will be binding upon and inure to the
            benefit of the parties hereto, their successors and permitted assigns.
            Either party may assign this Agreement in its entirety to a successor
            corporation upon notice to the other party in the event of a merger or
            an acquisition of all or substantially all of the assets of the
            assigning party. This agreement between DNAPRINT and CONSULTANT will
            survive and insure to the benefit of the other party through any and
            all mergers, acquisitions, or change in ownership.

        8.6 Governing Law. All questions concerning the validity, operation,
            interpretation, and construction of this Agreement will be governed by
            and determined in accordance with the laws of the State of Florida,
            without regard to its conflict of laws provisions. Application of the
            United Nations Convention on Contracts for the International Sale of
            Goods is specifically excluded.

        8.7 Severability. If a court of competent jurisdiction determines that any
            provision of this Agreement is invalid, illegal, or otherwise
            unenforceable, such provision shall be replaced with a valid,
            enforceable provision as nearly as possible in accordance with the
            stated intention of the parties, while the remainder of this Agreement

                                       7

            shall remain in full force and effect. To the extent any provision
            cannot be enforced in accordance with the stated intentions of the
            parties, such provision shall be deemed not to be a part of this
            Agreement.

        8.8 Counterparts. This agreement may be executed in any number of
            counterparts, all of which together will constitute one and the same
            instrument.

IN WITNESS THEREOF, the parties have caused this Agreement to be executed by
their respective duly authorized representatives as set forth below:

DNAPRINT GENOMICS                           CONSULTANT

By:/s/Tony Frudakis                         By:/s/Mark D. Shriver
Tony Frudakis, Ph.D.                           Mark D. Shriver, Ph.D.
CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}]]